High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135) using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes

Eitemau Tebyg

• Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N‐(adamantan‐1‐yl)‐1‐(5‐fluoropentyl)‐1H‐indole‐3‐carboxamide (STS‐135)
  gan: Jones, Sabrina, et al.
  Cyhoeddwyd: (2020)
• Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS
  gan: Gandhi, Adarsh S, et al.
  Cyhoeddwyd: (2014)
• Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS
  gan: Wohlfarth, Ariane, et al.
  Cyhoeddwyd: (2014)
• Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA
  gan: Wohlfarth, Ariane, et al.
  Cyhoeddwyd: (2015)
• Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation
  gan: Wohlfarth, Ariane, et al.
  Cyhoeddwyd: (2015)